Heparin Market Report

Heparin Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020

Format: PDF  |  Report ID: 476

Heparin is a blood thinner or an anticoagulant which is responsible for prevention of formation of blood clots. It is generally used in treatment of blood clot in veins, lungs, heart or even lungs. They are popularly used before surgery, during dialysis or during blood transfusion, when blood is taken as sampling. In other words they are generally used to reduce the risk of blood clotting. Apart from this it is also used to treat certain blood clot disorder. Basically it helps in keeping blood flowing smooth by making a certain natural substance in the body called anti-clotting protein which is also called as anticoagulant. 

Other than surgical use, it may be also prescribed by heath care professional to prevent blood clot in patients with certain type of heart attack or chest pain or angina. Heparin is injected under the skin or in the vein not into the muscle and amount of dosage depends upon the patient’s medical condition, response to treatment and the weight. Heparin is available in multiple strength range, and extreme precaution should be taken as it may also cause fatal injuries. Extreme precautions and instructions are advised to be followed for using Heparin. The regular use of Heparin could help in delivering best results.

Type of heparin used in pharmaceuticals is derived from specific mucosal tissues of meat from specific animal’s body parts such as pig’s intestine and cattle’s lungs. China having largest number of swineherd, so it is an essential to global heparin market. The supply chain of Heparin starts at slaughterhouses which are followed by various workshop which extracts basic heparin material also known as heparin crude from mucous membrane from pig intestine. Heparin crude is further sold to pharmaceutical manufacturers which after processing produce Heparin.

Other application includes heparin gel for treating sports injuries; lithium salt of heparin is used in test tubes as anticoagulant, heparin-coated blood oxygenators for heart lung diseases, Immobilized heparin is commonly used as aprotein purifier. It has a shelf life ranges from 18 months to 3 years depending upon the manufacturer. Lift of heparin export standards, global aging problem and increasing focus on research and development initiatives by drug manufactures are basic three drivers for the heparin market as a whole. Rise in economics like china and rise in healthcare expenditure are key opportunities in the area.

Asia-Pacific, North American and Row are expected to be prominent market for heparin growth over next six years due to comparative more healthcare problem in the region. European markets are expected to grow less steeply over next six years.

GlaxoSmithKline PLC, Pfizer Inc., Baxter Healthcare, ShandongEast Chemical Industry Co, Bristol-Myers Squibb Co., Leo Pharma Inc.Sanofi,Hisunny Chemical Co, and Leap Labchem Co are market leaders.

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA